Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT07063407 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07063407
Sponsor: Shanghai Hansoh Biomedical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2025-07-31
Primary completion: 2026-04-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.